塩野義薬：SAGE and SHIONOGI Enter Strategic Collaboration to Develop and Commercialize SAGE-217 for MDD and Other Indications in Japan, Taiwan and South Korea - 有報キャッチャー

塩野義薬（4507）　SAGE and SHIONOGI Enter Strategic Collaboration to Develop and Commercialize SAGE-217 for MDD and Other Indications in Japan, Taiwan and South Korea 2018/06/14

/-

読み込み中…